World Journal of
Pharmaceutical and Life Sciences

A COMPARATIVE CLINICAL STUDY OF VIDARIKANDA CHURNA AND KATAKA CHURNA IN THE MANAGEMENT OF MALE SEXUAL DYSFUNCTION AND POOR VISION

Dr. Shri Ram Saini* and Dr. B. K. Sevatkar

ABSTRACT

Background: Excessive sex induced stress hormones- epinephrine and nor-epinephrine may damage retinal endothelial cells, inflame eye balls and dilate pupils, over sensitivity to light in the retina and adverse effect on power of vision. Aim: To evaluate and compare the efficacy of Vidarikanda churna and Kataka churna in the management of Male sexual function and poor vision. Material and methods: 110 patients who have Timira (Refractive errors) with associated symptoms of Male sexual dysfunction (MSD) had selected for randomised control trial on the basis of prepared inclusion & exclusion criteria, out of them 50 patients each were divided in two groups (excluding drop outs) named Group A and group B. Results: The trial drug Kataka churna showed statistically significant results in subjective parameters of Visual disturbances (Timira roga) and visual acuity. Vidarikanda churna is significantly improved the quality of vision and MSD. Conclusion: The study is overall concluded that Shukravradhaka drugs like Vidarikanda is significantly improve the quality of vision. So, more & more Shukral drugs should be prescribed in the treatment of low visual acuity. Vidharikanda offers a good promise for the patients of low visual acuity and the research will pave the path for further research in this field.

[Full Text Article]   [Download Certificate]